CD ComputaBio provides AlphaFold Model Assessment for Docking to help researchers determine whether a predicted protein structure is reliable enough to support molecular docking, virtual screening, and binding-mode prediction. By combining per-residue confidence interpretation, binding-site geometry auditing, side-chain rotamer checking, and cross-validation against experimental data, our scientists connect protein structure modeling, pocket analysis, and docking confidence scoring into decision-ready reporting for drug discovery, target assessment, and lead optimization.
We map pLDDT and predicted alignment error onto the structure, segment the protein into confidence tiers, and identify whether the binding region falls within a reliable zone.
We assess pocket shape, volume, enclosure, and physicochemical surface properties to determine whether the predicted pocket is geometrically plausible for ligand accommodation.
We inspect side-chain conformations of binding-site residues, flag unreliable rotamers, and compare packing against known structural patterns or homologous templates.
When experimental structures, homologs, or mutagenesis data exist, we align and compare the AlphaFold model to quantify deviations in the binding region and overall fold.
For projects with several AlphaFold predictions, multimer states, or conformational alternatives, we rank models by docking suitability and recommend the most appropriate receptor.
We connect structural confidence to docking outcomes, flagging poses that depend on low-confidence regions and translating assessment findings into actionable docking guidance.
Predicted local distance difference test provides a per-residue confidence score. We segment the structure into high, medium, low, and very-low confidence zones and evaluate the binding region against this map.
Predicted aligned error reveals relative confidence between domains and at interfaces. We interpret PAE matrices to assess whether domain orientation and inter-domain geometry are trustworthy.
We calculate pocket volume, enclosure, mouth opening, and shape descriptors to judge whether the predicted binding cavity can physically accommodate the intended ligand class.
We evaluate binding-site side chains for rotamer plausibility, steric clashes, hydrogen-bond geometry, and consistency with known residue preferences in similar pockets.
When reference structures, cryo-EM maps, NMR data, or mutagenesis results are available, we align and compare to quantify local and global deviation of the AlphaFold model.
We correlate docking poses with underlying structural confidence, annotating which poses rest on reliable regions and which should be treated cautiously due to low-confidence contacts.
We clarify the downstream goal—virtual screening, pose prediction, binding-mode hypothesis, SAR interpretation, or lead optimization—so the assessment focuses on the structural features that matter most.
We obtain AlphaFold predictions from public databases or client-provided files, clean the structure, assign protonation states, handle missing residues, and prepare the model for confidence analysis.
We project pLDDT and PAE onto the structure, identify the binding region, and determine what fraction of the pocket falls within high-, medium-, or low-confidence zones.
We compute pocket descriptors, inspect binding-site side-chain rotamers, check for clashes or implausible conformations, and evaluate whether the cavity geometry supports ligand binding.
When experimental references or multiple predictions are available, we align structures, quantify deviations, rank alternatives, and recommend the most docking-suitable model.
We deliver a structured report with confidence maps, pocket diagnostics, side-chain notes, risk flags, model rankings, and explicit guidance on docking protocol and result interpretation.
| Research Question | Recommended Assessment Focus | Key Readouts | Decision Supported |
|---|---|---|---|
| Is this AlphaFold model good enough for docking? | pLDDT mapping, pocket confidence, side-chain audit | Binding-site confidence summary, risk flags, docking-readiness score | Proceed with docking, refine the model, or seek an alternative structure |
| Which of several predicted models should I dock against? | Multi-model comparison, pocket geometry, reference alignment | Ranked model list, RMSD to reference, pocket shape descriptors | Select the most reliable receptor for the docking campaign |
| Can I trust the docking poses I already generated? | Pose-to-confidence correlation, contact-level reliability | Confidence-weighted pose ranking, flagged high-risk contacts | Prioritize poses, identify artifacts, or rerun with an improved model |
| Does the predicted binding pocket match known SAR or mutagenesis? | Experimental cross-validation, residue-level comparison | Key-residue consistency, deviation map, SAR alignment notes | Validate or revise the binding hypothesis before further screening |
| Is the AlphaFold multimer interface reliable for protein-protein docking? | PAE interface analysis, inter-chain confidence, contact mapping | Interface confidence map, contact reliability, domain orientation score | Decide whether to use the predicted complex or refine the interface |
| Can I use AlphaFold for large-scale virtual screening? | Pocket enclosure, side-chain stability, confidence gating | Screening-readiness verdict, recommended protocol adjustments | Launch screening confidently or apply confidence-based pose filtering |
Before launching a large-scale virtual screening campaign on a target with no experimental structure, we verify that the AlphaFold pocket is reliable enough to produce meaningful enrichment.
When docking poses are used to rationalize SAR or guide lead optimization, we check whether key contacts rest on high-confidence residues or depend on unreliable side-chain predictions.
For targets with several predicted models, conformational states, or multimer assemblies, we rank alternatives by pocket quality and recommend the best receptor for the docking question.
We compare predicted binding-site residues with mutagenesis data and known SAR to confirm that the AlphaFold pocket is consistent with experimental observations before docking.
For antibody-antigen or protein-protein docking on AlphaFold multimer predictions, we evaluate interface confidence through PAE and contact reliability to gauge complex plausibility.
When the binding site borders flexible loops or disordered regions, we assess whether predicted conformations are reliable enough for docking or require alternative modeling strategies.
A high global pLDDT does not guarantee that the binding pocket is accurate enough for docking. Local confidence, side-chain rotamer quality, pocket geometry, and consistency with experimental data all determine whether docking results will be trustworthy. CD ComputaBio combines these dimensions into a single docking-readiness verdict so clients can act with confidence.
Goal: confirm that an AlphaFold structure can support a virtual screening campaign before investing compute resources.
Goal: determine whether existing docking poses are trustworthy enough to guide medicinal chemistry decisions.
Goal: choose the best AlphaFold model among several predictions for a flexible or multimeric target.
Not necessarily. A high global pLDDT indicates overall backbone accuracy, but the binding pocket may still contain unreliable side-chain conformations, ambiguous loop regions, or geometric issues that affect ligand placement. Local confidence, pocket geometry, and side-chain rotamer quality must be evaluated together to judge docking readiness.
Yes, but with caution. AlphaFold models can support virtual screening when the binding pocket falls within a high-confidence region and pocket geometry is plausible. We recommend a pre-screening assessment to confirm pocket reliability and, where possible, to apply confidence-based filtering of docking results.
When the binding pocket overlaps with low-confidence residues, options include refining the region through loop modeling or molecular dynamics, using an alternative AlphaFold model, incorporating experimental restraints, or treating docking results with appropriate caution. Our assessment report includes specific recommendations based on the severity and location of the uncertainty.
For multimer predictions, we analyze the predicted aligned error (PAE) matrix at the interface, evaluate inter-chain contact reliability, compare domain orientations, and cross-check against known interface residues or mutagenesis data. This determines whether the predicted complex is reliable enough for protein-protein docking or whether interface refinement is needed.
Typical inputs include the AlphaFold model file or UniProt identifier, the known or hypothesized binding site, the downstream docking objective, and any available experimental references such as crystal structures, cryo-EM maps, mutagenesis data, or SAR tables. Our team can help retrieve and prepare structures when only a target name or sequence is available.
Share your AlphaFold structure, binding-site information, and docking objective. Our team will assess per-residue confidence, pocket geometry, side-chain reliability, and experimental consistency, then deliver a docking-readiness verdict with clear next-step guidance for your screening or lead optimization campaign.
Submit Project DetailsSubmit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk